GRUPO CAROL, S.A.S. – Trademark Portfolio
Entity Type: 16
GRUPO CAROL, S.A.S. holds 3 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 35 (Advertising & Business) — 3 filings in this category. The portfolio also extends into Class 44 (Medical Services) across 2 Nice Classification classes. Currently, 3 trademarks are registered. Notable registered marks include CAROL FARMACIA RX, CON CAROL CERCA TE SENTIRÁS MÁS TRANQUILO, and FARMACIA CAROL ¡SERVIR ES NUESTRA PASIÓN!. The owner is based in Santo Domingo, D.N..
Av. 27 de Febrero No. 221
Santo Domingo, D.N. 10121 , DO
Showing of trademarks Trademarks
Trademark Classifications
GRUPO CAROL, S.A.S.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Advertising; business management; business administration; office functions
Medical services; veterinary services; hygienic and beauty care for human beings or animals
Frequently Asked Questions
How many trademarks does GRUPO CAROL, S.A.S. have?
GRUPO CAROL, S.A.S. has 3 U.S. trademarks filed with the USPTO. Of these, 3 registered.
What trademark classes does GRUPO CAROL, S.A.S. file in?
GRUPO CAROL, S.A.S. files trademarks across 2 Nice Classification classes. The most active classes are Class 35 (Advertising & Business), Class 44 (Medical Services). Class 35 covers advertising; business management; business administration; office functions.
What are GRUPO CAROL, S.A.S.'s most well-known trademarks?
GRUPO CAROL, S.A.S.'s registered trademark portfolio includes well-known marks such as CAROL FARMACIA RX, CON CAROL CERCA TE SENTIRÁS MÁS TRANQUILO, and FARMACIA CAROL ¡SERVIR ES NUESTRA PASIÓN!. These are among 3 currently registered trademarks in the portfolio.
What is GRUPO CAROL, S.A.S.'s trademark registration success rate?
GRUPO CAROL, S.A.S. has a 100% trademark registration rate, with 3 out of 3 resolved applications resulting in successful registration. Currently, 0 applications are pending review.